Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells.

Differences between treatments were deemed to be extremely significant, very significant, significant and not significant if their P values (according to Bonferroni’s comparison test) were < 0.001, < 0.01, 0.01 < P < 0.05, and > 0.05, respectively.

also in 7,787 other papers